FINDEX Inc. (TYO:3649)
Japan · Delayed Price · Currency is JPY | Market Cap | 22.51B -1.9% |
| Revenue (ttm) | 5.90B -2.0% |
| Net Income | 1.18B -10.5% |
| EPS | 46.62 -9.6% |
| Shares Out | 24.41M |
| PE Ratio | 19.78 |
| Forward PE | 17.39 |
| Dividend | 18.00 (1.94%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 143,800 |
| Average Volume | 93,140 |
| Open | 937.00 |
| Previous Close | 922.00 |
| Day's Range | 886.00 - 955.00 |
| 52-Week Range | 598.00 - 1,011.00 |
| Beta | 0.28 |
| RSI | 52.99 |
| Earnings Date | Feb 12, 2026 |
About FINDEX
FINDEX Inc. offers medical systems, office systems, and medical equipment solutions in Japan. It operates through three segments: Medical Business, Public Business, and Healthtech Business. The company provides Claio image filing system, C-Scan paper and digital document management system, DocuMaker document creation system, PDI+MoveBy referral information management system, C-Note medical record writing system, MapleNote perinatal system, REMORA electronic medical record, ID-Cam/Claio-Cam digital camera solution, UniversalSearcher medical big ... [Read more]
Financial Performance
In 2024, FINDEX's revenue was 5.84 billion, an increase of 12.52% compared to the previous year's 5.19 billion. Earnings were 1.16 billion, an increase of 9.73%.
Financial StatementsNews
PE-backed Findex set to restock coffers with $400m refinancing
Skye Capital is expected to spend the coming weeks collecting feedback from funds on the deal structure, including size and pricing.